Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Translational Study in Patients With COPD and Pre-COPD to Describe Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population

NCT06724848 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06724848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06724848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Translational Study in Patients With COPD and Pre-COPD to Describe Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
June 5, 2024
Completion date
October 21, 2027
Enrollment
850 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

copd